Guowen Lin

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

TRIM17 downregulation modulates CRPC progression and enzalutamide resistance by derepressing BCL2 expression via the p53-dependent and p53-independent pathways.

TRIM17 downregulation modulates CRPC progression and enzalutamide resistance by derepressing BCL2 expression via the p53-dependent and p53-independent pathways.

Journal: Cell death and differentiation

Published: July 21, 2025

Plasma Proteomic Profiling Was Used to Discover a Biochemical Recurrence Prediction Model for Prostate Cancer.

Plasma Proteomic Profiling Was Used to Discover a Biochemical Recurrence Prediction Model for Prostate Cancer.

Journal: Molecular & cellular proteomics : MCP

Published: May 19, 2025

Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer.

Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: September 28, 2024

MYO6 contributes to tumor progression and enzalutamide resistance in castration-resistant prostate cancer by activating the focal adhesion signaling pathway.

MYO6 contributes to tumor progression and enzalutamide resistance in castration-resistant prostate cancer by activating the focal adhesion signaling pathway.

Journal: Cell communication and signaling : CCS

Published: June 18, 2024

Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer.

Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer.

Journal: Cancer biology & medicine

Published: February 06, 2024

IL-17RA/CTSK axis mediates H. pylori-induced castration-resistant prostate cancer growth.

IL-17RA/CTSK axis mediates H. pylori-induced castration-resistant prostate cancer growth.

Journal: Oncogene

Published: January 26, 2024

Role of gut microbiota in the pathogenesis of castration-resistant prostate cancer: a comprehensive study using sequencing and animal models.

Role of gut microbiota in the pathogenesis of castration-resistant prostate cancer: a comprehensive study using sequencing and animal models.

Journal: Oncogene

Published: November 30, 2023

Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression.

Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression.

Journal: Cell death discovery

Published: August 13, 2023

Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity.

Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity.

Journal: Molecular oncology

Published: January 30, 2023

Deubiquitinase USP35 stabilizes BRPF1 to activate mevalonate (MVA) metabolism during prostate tumorigenesis.

Deubiquitinase USP35 stabilizes BRPF1 to activate mevalonate (MVA) metabolism during prostate tumorigenesis.

Journal: Cell death discovery

Published: April 26, 2022

Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate.

Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate.

Journal: Military Medical Research

Published: July 12, 2021

Inherited Mutations in Chinese Men With Prostate Cancer.

Inherited Mutations in Chinese Men With Prostate Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: October 08, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026